Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
15 December 1993 | Volume 119 Issue 12 | Pages 1223-1224
We found Dr. Saleh's observation and comments interesting. The reduction of chyluria with an ACE inhibitor is indeed a novel observation that will require confirmation by prospective studies. If confirmed, the mechanism could be a hemodynamic effect on the lymphatic circulation, resulting in reduction of chyluria. We are aware of one report claiming that an ACE inhibitor reduced the amount of protein lost across the peritoneal membrane in patients undergoing peritoneal dialysis [1]. A link could exist between these isolated observations.
1. Coronel F, Hortal L, Naranjo P, Cruceyra A, Barrientos A. Captopril, proteinuria and peritoneal protein leakage in diabetic patients (Letter). Nephron. 1989; 51:443. About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
REPLY
Angiotensin-converting-Enzyme Inhibitors and Chyluria
IN RESPONSE:
REFERENCE
![]()
Top
REFERENCE
![]()
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
This article has been cited by other articles:
![]() |
D. H. Elbe and S. W Chang Moxifloxacin-Warfarin Interaction: A Series of Five Case Reports Ann. Pharmacother., February 1, 2005; 39(2): 361 - 364. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||